Albano, Luigi
Emedoli, Daniele
Basaia, Silvia
Balestrino, Roberta
Pompeo, Edoardo
Barzaghi, Lina Raffaella
Iannaccone, Sandro
Mortini, Pietro
Agosta, Federica
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Article History
Received: 15 June 2022
Revised: 2 August 2022
Accepted: 2 August 2022
First Online: 20 August 2022
Declarations
:
: L. Albano was a recipient of the Lars Leksell Fellowship. D. Emedoli, S. Basaia, R. Balestrino, E. Pompeo, L.R. Barzaghi, S. Iannaccone and P. Mortini report no disclosures. F. Agosta is Section Editor of neuroimage: Clinical; has received speaker honoraria from Biogen Idec, Roche and Zambon; and receives or has received research supports from the Italian Ministry of Health, Arisla (Fondazione Italiana di Ricerca per la SLA), Fondation Recherche Alzheimer (France) and the European Research Council. M. Filippi is Editor-in-Chief of the Journal of Neurology, Associate Editor of <i>Human Brain Mapping</i>, Associate Editor of <i>Radiology</i>, and Associate Editor of <i>Neurological Sciences</i>; received compensation for consulting services and/or speaking activities from Alexion, Almirall, Bayer, Biogen, Celgene, Eli Lilly, Genzyme, Merck-Serono, Neopharmed Gentili, Novartis, Roche, Sanofi, Takeda, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).
: Written informed consent in respect of this case report was obtained in accordance with the Declaration of Helsinki. No ethics board approval was required for this case report.